In May 2017, IFPMA brought together industry leaders, senior policymakers, and representations from the diplomatic community, as well as key global health stakeholders attending the World Health Assembly, to discuss immunisation and prevention. The event explored how a life-course approach can contribute to a healthy and productive population.
With the number of people aged 65 or older expected to triple to 1.5 billion by 2050, this is an increasing priority for policymakers and an issue that requires urgent progress.
• Dr John Beard, Director Ageing and Life Course Dept, World Health Organization
The challenge of healthcare for an ageing population and the need for action
• Baroness Sally Greengross, Co-President, International Longevity Centre
Changing societies and developing the right policies to support an ageing population
• Ms Lois Privor-Dumm, Managing Director, Johns Hopkins Bloomberg School of Public Health
Perspectives on decision-making for life-course vaccination in low and middle income countries
• Dr Rajeev Venkayya – President, Global Vaccine Business, Takeda Pharmaceuticals
The role of industry to support innovation and delivery of vaccines
The event was chaired by Ms Zeinab Badawi.
Edited video highlights and the full event can be seen below.